CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 76 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,926 | -43.0% | 15,965 | -0.1% | 0.00% | – |
| Q2 2023 | $19,180 | -54.3% | 15,983 | -31.2% | 0.00% | – |
| Q1 2022 | $42,000 | +10.5% | 23,231 | -6.3% | 0.00% | – |
| Q4 2021 | $38,000 | +26.7% | 24,805 | +70.5% | 0.00% | – |
| Q3 2021 | $30,000 | -70.9% | 14,550 | -50.6% | 0.00% | – |
| Q2 2021 | $103,000 | – | 29,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Bridge Compliance, LLC | 154,130 | $105,487 | 0.03% |
| CHELSEA COUNSEL CO | 81,300 | $55,642 | 0.03% |
| Inspire Advisors, LLC | 186,410 | $127,579 | 0.02% |
| Horst & Graben Wealth Management LLC | 75,722 | $51,824 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 198,492 | $136 | 0.01% |
| Arkadios Wealth Advisors | 100,000 | $68,440 | 0.01% |
| Miller Investment Management, LP | 50,000 | $34,220 | 0.01% |
| XTX Topco Ltd | 29,077 | $19,900 | 0.00% |
| Measured Wealth Private Client Group, LLC | 10,000 | $6,844 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $7,504 | 0.00% |